Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women
Author(s) -
Angela Huttner,
Anna Kowalczyk,
Adi Turjeman,
Tanya Babich,
Caroline Brossier,
Noa EliakimRaz,
Katarzyna Kosiek,
Begoña Martínez de Tejada,
Xavier Roux,
Shachaf Shiber,
Ursula Theuretzbacher,
Elodie von Dach,
Dafna Yahav,
Leonard Leibovici,
Maciek Godycki-Ćwirko,
Johan W. Mouton,
Stephan Harbarth
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.3627
Subject(s) - medicine , nitrofurantoin , fosfomycin , dysuria , discontinuation , interquartile range , urinary system , randomized controlled trial , clinical trial , adverse effect , outpatient clinic , surgery , antibiotics , ciprofloxacin , microbiology and biotechnology , biology
The use of nitrofurantoin and fosfomycin has increased since guidelines began recommending them as first-line therapy for lower urinary tract infection (UTI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom